ArticleBioinformation2026
Sarcopenia with postoperative outcomes in patients undergoing pancreaticoduodenectomy.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of sarcopenia in patients undergoing pancreaticoduodenectomy (PD) for pancreatic and periampullary tumors and its impact on postoperative outcomes is highly relevant. Therefore, it is of interest to investigate the prevalence of sarcopenia in patients undergoing pancreaticoduodenectomy (PD) for pancreatic and periampullary tumors. A prospective observational analysis of 50 patients revealed that sarcopenia, assessed through Psoas Muscle Index, Hand Grip Strength and Gait Speed, is a significant predictor of postoperative outcomes. Age did not notably affect sarcopenia prevalence, while factors such as gender, ECOG status and diabetes were identified as key risk factors. Gait speed was found to be the strongest predictor of mortality, emphasizing its potential as a primary diagnostic tool. The identification of sarcopenia as a significant predictor of postoperative outcomes in pancreaticoduodenectomy patients with gait speed emerging as the strongest predictor of mortality, offering a potential tool for preoperative assessment and improved patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.